ArticleRheumatology advances in practice2020

Use of biologic or targeted-synthetic disease-modifying anti-rheumatic drugs and risk of diabetes treatment intensification in patients with rheumatoid arthritis and diabetes mellitus.

Sarah K Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.